Geert Cauwenbergh, Ph.D.
CEO and Chairman
Barrier Therapeutics, Inc.
|
2005 High-Tech Business Leader Category
Geert
Cauwenbergh, Ph.D., Chairman and Chief Executive Officer, is the founder
of Barrier
Therapeutics. Prior to founding Barrier, Dr. Cauwenbergh was Vice
President of Technology of the Johnson & Johnson (J&J) Consumer
and Personal Care Products Companies. In this capacity, he created
technology platforms based on intellectual property and know-how owned
by Johnson & Johnson, and developed a business proposition around
these platforms as the basis for new companies or new businesses within
J&J. The creation of Barrier Therapeutics as a separate company
devoted to the clinical development and commercialization of
dermatological products in-licensed from J&J affiliates is a direct
consequence of his efforts in this area.
Previously,
Geert served as Vice President of Research & Development of the
J&J Consumer Companies Worldwide, managing a global organization of
over 100 people, with an annual budget of $35 million, and he also was a
member of the J&J Business Development Council. In 1994, Dr.
Cauwenbergh became Vice President of Product Development and a member of
the Management Board of the US J&J Consumer Company. He also was the
Director of the Corporate Skin Care Council of J&J, coordinating the
skin care activities in the different operating groups of the
Corporation.
Earlier
in his career, he held positions in sales, and national and
international marketing, and he was responsible for the successful
global introduction of Nizoral® (ketoconazole).
Geert joined the R&D organization of the Janssen Research Foundation
in 1982, where he held positions of increasing global responsibility and
oversaw development of drugs such as Sporanox®,
Nizoral® Shampoo,
Terazol®,
and topical Sufrexa®.
His R&D activities have also involved him in the fields of
psoriasis, acne, wound healing, atopic dermatitis, protozoal infections,
and HIV.
Dr.
Cauwenbergh has authored over 100 publications and co-authored several
books. He received his Ph.D. in Medical Sciences from the Catholic
University of Leuven, Faculty of Medicine, where he also completed his
Masters and undergraduate work.
|
